{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Palm Harbor",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89808",
      "recalling_firm": "Drug Depot, Inc., dba APS Pharmacy",
      "address_1": "34911 Us Highway 19 N Ste 600",
      "address_2": "N/A",
      "postal_code": "34684-1921",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA including Puerto Rico.",
      "recall_number": "D-0730-2022",
      "product_description": "TESTOSTERONE CYPIONATE/ANASTROZOLE *GS* OIL 200MG/1MG/ML  Injectable, Packaged in a multi dose 10ML vial, as a) 4 ML Formula ID 115387; b) (RM) 10 ML Formula ID 115125; APS Pharmacy",
      "product_quantity": "846 vials",
      "reason_for_recall": "Lack of sterility assurance.",
      "recall_initiation_date": "20220323",
      "center_classification_date": "20220329",
      "termination_date": "20231005",
      "report_date": "20220406",
      "code_info": "Lots: a) 745383 BUD: 6/20/2022; 759295 BUD: 8/30/2022; b) 745749 BUD: 6/21/2022; 746272 BUD: 6/27/2022"
    }
  ]
}